Recent ABOS Stock Price | ABOS Stock Predictions | |
$3.47 | +339.48% |
$15.25 |
Recent ABOS Analyst Ratings Breakdown, Making ABOS Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 5 | 6 | 6 | 6 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the ABOS stock predictions from the analysts covering Acumen Pharmaceuticals Inc, we have collected all of the individual ABOS stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 4 different analysts covering ABOS (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ABOS stock predictions may vary widely, another useful metric to consider is the median ABOS stock prediction, which represents the price at which half of the analysts
made ABOS stock predictions that were higher and half made ABOS stock predictions that were lower. This makes for a different take on the ABOS stock predictions out there, as compared to average or mean.
And that median across all the individual ABOS stock predictions was: $14.5 as of 2024-04-18.
The very highest of the ABOS stock predictions for one year price target was $22.0, while the very lowest of the ABOS stock predictions in the analyst group was
$10.0 (with a standard deviation of $4.991). Get the latest Zacks research report on ABOS — FREE
Find out: ABOS next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
EMKR Stock Predictions
WERN Stock Predictions
RC Stock Predictions
NKSH Stock Predictions
SHLX Stock Predictions
GWRE Stock Predictions
UMPQ Stock Predictions
ENV Stock Predictions
ALX Stock Predictions
|
|
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |